Showing 2,673 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

AbbVie 3D HCV regimen well-tolerated in PEARL trials

News
24 October 2014
Hepatitis C treatment

Ireland: Hepatitis C drug to be made available

Editor's pick
The Irish Times
22 October 2014
Hepatitis C treatment

Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

Editor's pick
Poz magazine news
22 October 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir safe and effective for genotype 1 HCV

News
20 October 2014
Hepatitis C transmission & prevention

HCV sexual transmission: HIV negative may be at risk, more awareness and testing needed

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis & HIV

Coffee, Even Decaf, May Promote Liver Health

Editor's pick
AIDSMeds
16 October 2014
New & experimental hepatitis C treatment

IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis C treatment

Unique 'pay if you clear' proposal for new hepatitis drug

Editor's pick
BBC
15 October 2014
Hepatitis C transmission & prevention

Egypt: Poor infection control to blame for hepatitis C epidemic

Editor's pick
Nature Middle East
15 October 2014
New & experimental hepatitis C treatment

Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

Editor's pick
Fair Pricing Coalition
15 October 2014
Pharmaceutical industry

If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Editor's pick
Wall Street Journal
15 October 2014
Hepatitis C symptoms & diagnosis

HCV core-antigen testing is a reliable way of detecting acute HCV infections in HIV-positive gay men

News
13 October 2014
Hepatitis C treatment

As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

Editor's pick
Forbes
10 October 2014
New & experimental hepatitis C treatment

U.S. Food and Drug Administration Approves Gilead’s Harvoni® (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C

Editor's pick
Gilead press release
10 October 2014
Hepatitis C treatment

Thousands of Hep C patients in Alexandria wait in long lines to receive Sovaldi

Editor's pick
Egypt Independent
10 October 2014
Hepatitis C treatment

Sovaldi ‘unaffordable’ says NHS documents

Editor's pick
Pharmafile
8 October 2014
New & experimental hepatitis C treatment

In a surprise move, Bristol-Myers drops U.S. approval plans for hep C drug

Editor's pick
Fierce Biotech
7 October 2014
Hepatitis C treatment

CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill

Editor's pick
Forbes
7 October 2014
Hepatitis C treatment

Most Spanish patients coinfected with HIV/HCV called difficult to cure

Editor's pick
Healio
7 October 2014
Hepatitis C treatment

New Hepatitis C Treatment Too Pricey For All Patients

Editor's pick
KJZZ Radio
7 October 2014
Hepatitis B

People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening

News
2 October 2014
Hepatitis C transmission & prevention

Investigating an outbreak of hepatitis C virus among MSM without HIV

Editor's pick
CATIE
1 October 2014
Pharmaceutical industry

J&J makes a splash in hep C with a $1.75B deal for Alios

Editor's pick
Fierce Biotech
1 October 2014
Hepatitis C treatment

France uses tax to put pressure on hepatitis C drug prices

Editor's pick
Reuters
1 October 2014